44 results
8-K
EX-1.2
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
believes to be (i) a QIB or (ii) an institutional “accredited investor”.
Section 2. Engagement of Placement Agents; Fees; Expenses.
(a) Engagement … to place the Shares and the PFWs as contemplated by this Agreement. The Company acknowledges that the Placement Agents’ engagement hereunder does
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
10 Jul 23
Regulation FD Disclosure
4:06pm
quarter 2023 24 | © 2023 Soleno Therapeutics
Scientific Outreach & Community Engagement Increasing levels of engagement with PWS community, physicians
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
15 Nov 19
Departure of Directors or Certain Officers
4:37pm
position at another client and as a result will no longer be available to continue his engagement as the FLG Member;
WHEREAS, FLG and Client have agreed
8-K
SLNO
Soleno Therapeutics Inc
15 Nov 19
Departure of Directors or Certain Officers
4:37pm
of his decision to accept a full-time position at another company and therefore was no longer available to continue his engagement with the Company
424B3
fbyz2h u1
24 Jul 17
Prospectus supplement
12:00am
S-1/A
EX-3.3
bj8j7 rg2y0yy7u
1 Jul 14
IPO registration (amended)
12:00am
8-K
EX-10.1
qqp8fjv i62
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-1/A
EX-3.4
bwwu8a
1 Jul 14
IPO registration (amended)
12:00am